Sachs 3rd Annual Neuroscience Innovation Forum
Webcast: Watch Dr. Elliot Goldstein discuss the ProMIS pipeline and explain how 2020 will be marked by momentum and hope for Alzheimer’s Disease from the Sachs Neuroscience Innovation Forum.
PMN310 has been granted Fast Track Designation by the U.S. FDA for the treatment of Alzheimer’s disease.